secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2024-12-09T23:59:59+00:00
Accession:  0001213900-24-106933
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell VP of Manufacturing to retire July 2025; enters separation agreement
-----------------------------------------------------------------------------

- Elizabeth L. Williams moves to part-time effective Dec 7, 2024; retires July 1, 2025.
- She will work ≤10 hrs/week transitioning tasks; all prior employment agreements terminated.
- Eligible for $100,000 transition incentive if she works through June 30, 2025 and signs affirmation.
- Outstanding stock options continue to vest per plan terms until separation date.
- During transition she accrues no PTO and loses group health coverage (COBRA available at own cost).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390024106933/0001213900-24-106933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390024106933/ea0224119-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-106933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer